Dermata Therapeutics annual shares outstanding
2021
2022
2023
2024
2025
Dermata Therapeutics Shares Outstanding History (DRMA)
Dermata Therapeutics reported 2.7M shares outstanding at the end of fiscal 2025.
View full Dermata Therapeutics company overviewDermata Therapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.7M | 2.4M | +956.75% |
| 2024 | 2024-12-31 | 251,725 | −10,273 | −3.92% |
| 2023 | 2023-12-31 | 261,998 | −508,117 | −65.98% |
| 2022 | 2022-12-31 | 770,115 | −7.6M | −90.75% |
| 2021 | 2021-12-31 | 8.3M | — | — |
Dermata Therapeutics quarterly shares outstanding
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 4.0M | 3.4M | +530.67% |
| Q1 2026 | 2026-03-31 | 4.0M | −2.0M | −33.33% |
| Q4 2025 | 2025-12-31 | 2.7M | 142,342 | +5.65% |
| Q3 2025 | 2025-09-30 | 844,457 | −833,311 | −49.67% |
| Q2 2025 | 2025-06-30 | 637,757 | −55,418 | −7.99% |
| Q1 2025 | 2025-03-31 | 6.0M | −628,192 | −9.43% |
| Q4 2024 | 2024-12-31 | 2.5M | −1.4M | −35.95% |
| Q3 2024 | 2024-09-30 | 1.7M | −1.5M | −47.39% |
| Q2 2024 | 2024-06-30 | 693,175 | −2.5M | −78.26% |
| Q1 2024 | 2024-03-31 | 6.7M | 4.3M | +178.91% |
| Q4 2023 | 2023-12-31 | 3.9M | 3.2M | +410.42% |
| Q3 2023 | 2023-09-30 | 3.2M | −8.9M | −73.65% |
| Q2 2023 | 2023-06-30 | 3.2M | −6.9M | −68.43% |
| Q1 2023 | 2023-03-31 | 2.4M | −5.9M | −71.33% |
| Q4 2022 | 2022-12-31 | 770,115 | −7.6M | −90.75% |
| Q3 2022 | 2022-09-30 | 12.1M | 3.8M | +45.31% |
| Q2 2022 | 2022-06-30 | 10.1M | 8.2M | +428.63% |
| Q1 2022 | 2022-03-31 | 8.3M | — | — |
| Q4 2021 | 2021-12-31 | 8.3M | — | — |
| Q3 2021 | 2021-09-30 | 8.3M | — | — |
| Q2 2021 | 2021-06-30 | 1.9M | — | — |
Dermata Therapeutics shares outstanding trends
Across the available reported history, Dermata Therapeutics's shares outstanding moved from 251,725 to 2.7M, a change of 2.4M. The latest reported quarter, Q2 2026, shows 4.0M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dermata Therapeutics filings at SEC.gov ↗